{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:50:40Z","timestamp":1775004640621,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005496","name":"American Foundation for Pharmaceutical Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005496","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.japh.2021.06.004","type":"journal-article","created":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T14:29:03Z","timestamp":1623421743000},"page":"753-760.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Community pharmacists in Virginia dispensing naloxone under a standing order: A qualitative study"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5270-0832","authenticated-orcid":false,"given":"Stephen C.","family":"Ijioma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena V.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon B.","family":"Gatewood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norman V.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa M.","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.japh.2021.06.004_bib3","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/MLR.0000000000000625","article-title":"The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013","volume":"54","author":"Florence","year":"2016","journal-title":"Med Care"},{"key":"10.1016\/j.japh.2021.06.004_bib5","series-title":"Narcan (naloxone) [package insert]","year":"2015"},{"issue":"11","key":"10.1016\/j.japh.2021.06.004_bib7","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1111\/pme.12480","article-title":"Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients","volume":"15","author":"Zedler","year":"2014","journal-title":"Pain Med"},{"issue":"2S","key":"10.1016\/j.japh.2021.06.004_bib8","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1016\/j.japh.2016.11.007","article-title":"State legal innovations to encourage naloxone dispensing","volume":"57","author":"Davis","year":"2017","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"2","key":"10.1016\/j.japh.2021.06.004_bib9","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.sapharm.2018.04.002","article-title":"Reviewing state-mandated training requirements for naloxone-dispensing pharmacists","volume":"15","author":"Roberts","year":"2019","journal-title":"Res Social Adm Pharm"},{"issue":"4S","key":"10.1016\/j.japh.2021.06.004_bib13","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.japh.2018.04.025","article-title":"Identifying barriers to dispensing naloxone: a survey of community pharmacists in North Carolina","volume":"58","author":"Rudolph","year":"2018","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"4","key":"10.1016\/j.japh.2021.06.004_bib14","first-page":"272","article-title":"Naloxone availability and pharmacy staff knowledge of standing order for naloxone in Pennsylvania pharmacies","volume":"13","author":"Graves","year":"2019","journal-title":"J\u00a0Addict Med"},{"issue":"3","key":"10.1016\/j.japh.2021.06.004_bib15","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1080\/08897077.2017.1391924","article-title":"Barriers and facilitators to dispensing of intranasal naloxone by pharmacists","volume":"39","author":"Bakhireva","year":"2018","journal-title":"Subst Abus"},{"issue":"1","key":"10.1016\/j.japh.2021.06.004_bib16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/08897077.2015.1132294","article-title":"Barriers to implementation of opioid overdose prevention programs in Ohio","volume":"37","author":"Winstanley","year":"2016","journal-title":"Subst Abus"},{"issue":"2S","key":"10.1016\/j.japh.2021.06.004_bib17","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/j.japh.2016.12.070","article-title":"Pharmacists\u2019 readiness to provide naloxone in community pharmacies in West Virginia","volume":"57","author":"Thornton","year":"2017","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"5","key":"10.1016\/j.japh.2021.06.004_bib18","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.japh.2020.03.005","article-title":"Revisiting pharmacy-based naloxone with pharmacists and naloxone consumers in 2 states: 2017 perspectives and evolving approaches","volume":"60","author":"Green","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"key":"10.1016\/j.japh.2021.06.004_bib19","series-title":"The Handbook of Behavior Change","first-page":"17","article-title":"Changing behavior using the theory of planned behavior","author":"Ajzen","year":"2020"},{"issue":"8","key":"10.1016\/j.japh.2021.06.004_bib20","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.sapharm.2018.10.027","article-title":"Using the theory of planned behavior to investigate community pharmacists\u2019 beliefs regarding engaging patients about prescription drug misuse","volume":"15","author":"Fleming","year":"2019","journal-title":"Res Social Adm Pharm"},{"issue":"3","key":"10.1016\/j.japh.2021.06.004_bib21","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.sapharm.2013.07.004","article-title":"Theoretical exploration of Tennessee community pharmacists\u2019 perceptions regarding opioid pain reliever abuse communication","volume":"10","author":"Hagemeier","year":"2014","journal-title":"Res Social Adm Pharm"},{"issue":"6","key":"10.1016\/j.japh.2021.06.004_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","year":"2007","journal-title":"Int J Qual Health Care"},{"issue":"4","key":"10.1016\/j.japh.2021.06.004_bib24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/hbe2.195","article-title":"The theory of planned behavior: frequently asked questions","volume":"2","author":"Ajzen","year":"2020","journal-title":"Hum Behav Emerg Technol"},{"issue":"1","key":"10.1016\/j.japh.2021.06.004_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/1468794107085301","article-title":"Naturalistic inquiry and the saturation concept: a research note","volume":"8","author":"Bowen","year":"2008","journal-title":"Qual Res"},{"issue":"1","key":"10.1016\/j.japh.2021.06.004_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2648.2007.04569.x","article-title":"The qualitative content analysis process","volume":"62","author":"Elo","year":"2008","journal-title":"J\u00a0Adv Nurs"},{"issue":"5","key":"10.1016\/j.japh.2021.06.004_bib27","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1188\/14.ONF.545-547","article-title":"The use of triangulation in qualitative research","volume":"41","author":"Carter","year":"2014","journal-title":"Oncol Nurs Forum"},{"issue":"1","key":"10.1016\/j.japh.2021.06.004_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/swr\/svu028","article-title":"The eye regards itself: benefits and challenges of reflexivity in qualitative social work research","volume":"39","author":"Probst","year":"2015","journal-title":"Soc Work Res"},{"key":"10.1016\/j.japh.2021.06.004_bib29","series-title":"Encyclopedia of Case Study Research","first-page":"290","article-title":"Deviant case analysis","author":"Wicks","year":"2013"},{"issue":"1","key":"10.1016\/j.japh.2021.06.004_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/08897077.2016.1184739","article-title":"Opioid overdose prevention through pharmacy-based naloxone prescription program: innovations in health care delivery","volume":"38","author":"Bachyrycz","year":"2017","journal-title":"Subst Abus"},{"key":"10.1016\/j.japh.2021.06.004_bib31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.drugalcdep.2018.03.032","article-title":"Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016","volume":"188","author":"Meyerson","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.japh.2021.06.004_bib32","author":"Doucette"},{"issue":"2S","key":"10.1016\/j.japh.2021.06.004_bib33","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.japh.2016.12.064","article-title":"Pharmacists\u2019 role in opioid overdose: Kentucky pharmacists\u2019 willingness to participate in naloxone dispensing","volume":"57","author":"Freeman","year":"2017","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"8","key":"10.1016\/j.japh.2021.06.004_bib34","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cptl.2018.05.016","article-title":"Pharmacists\u2019 knowledge, support, and perceived roles associated with providing naloxone in the community","volume":"10","author":"Stewart","year":"2018","journal-title":"Curr Pharm Teach Learn"},{"issue":"2","key":"10.1016\/j.japh.2021.06.004_bib35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.japh.2019.11.004","article-title":"Pharmacist attitudes toward pharmacy-based naloxone: a cross-sectional survey study","volume":"60","author":"Burstein","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"3","key":"10.1016\/j.japh.2021.06.004_bib36","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.japh.2019.11.024","article-title":"Naloxone availability and dispensing in Indiana pharmacies 2 years after the implementation of a statewide standing order","volume":"60","author":"Eldridge","year":"2020","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"2","key":"10.1016\/j.japh.2021.06.004_bib37","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/j.japh.2017.01.017","article-title":"Pharmacy-based statewide naloxone distribution: a novel \u201ctop-down, bottom-up\u201d approach","volume":"57","author":"Morton","year":"2017","journal-title":"J\u00a0Am Pharm Assoc (2003)"},{"issue":"3","key":"10.1016\/j.japh.2021.06.004_bib38","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.18549\/PharmPract.2020.3.2160","article-title":"Primary healthcare policy and vision for community pharmacy and pharmacists in the United States","volume":"18","author":"Salgado","year":"2020","journal-title":"Pharm Pract (Granada)"},{"key":"10.1016\/j.japh.2021.06.004_bib39","author":"Davis"},{"key":"10.1016\/j.japh.2021.06.004_bib40","author":"Hicks"},{"issue":"4","key":"10.1016\/j.japh.2021.06.004_bib41","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.18549\/PharmPract.2020.4.1865","article-title":"Evaluation of simulated drug dispensing and patient counseling in the course of pharmaceutical improvement: 2009 to 2015","volume":"18","author":"Packeiser","year":"2020","journal-title":"Pharm Pract (Granada)"},{"issue":"12","key":"10.1016\/j.japh.2021.06.004_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019462","article-title":"Mystery shopping and coaching as a form of audit and feedback to improve community pharmacy management of non-prescription medicine requests: an intervention study","volume":"7","author":"Collins","year":"2017","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.japh.2021.06.004_bib43","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.18549\/PharmPract.2019.4.1661","article-title":"Use of secret simulated patient followed by workshop based education to assess and improve inhaler counseling in community pharmacy in Jordan","volume":"17","author":"Elayeh","year":"2019","journal-title":"Pharm Pract (Granada)"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319121002715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319121002715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:48:19Z","timestamp":1761544099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319121002715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1544319121002715"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2021.06.004","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Community pharmacists in Virginia dispensing naloxone under a standing order: A qualitative study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2021.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}